The mountain section whose collapse triggered deadly floods in Nepal and China on August 26 experienced exceptionally high temperatures in the days before the disaster, according to meteorological data reconstructed and analysed
On February 26, 1852, the HMS Birkenhead struck a cluster of rocks off the coast of South Africa. With only a few lifeboats for the 638 people aboard, Captain Robert Salmond ordered the women
More
The long American century is over. Across the world, affiliations and institutions staked in blood and soil, faith-based (as opposed to empirically based) ways of knowing, and personalized, autocratic power are all
More
The perennial endeavor to distinguish prose from poetry has occupied poets, philosophers, and scholars through the centuries, each attempting to hold in place two forms of expression that appear, at once, kindred
More
A new genetic study of over one million people has found that many psychiatric disorders share common biological underpinnings, challenging traditional diagnostic categories, according to research published today in Nature. The analysis
More
Despite years of international discussions and white papers on AI governance, there has been no globally agreed framework to manage the risks and benefits of AI. As reported in Nature, China is
More
Cognitive fatigue, the mental exhaustion that can sap motivation, dull focus, and increase the likelihood of errors, affects billions of people worldwide. The phenomenon was famously highlighted in 1996 when chess grandmaster
More
Meta Platforms Inc. CEO Mark Zuckerberg is intensifying his personal involvement in the company’s artificial intelligence efforts as Meta pivots toward a new, revenue-focused model codenamed Avocado, according to sources cited by
More
Chinese artificial intelligence startup DeepSeek is said to have relied on Nvidia Corp. chips that are banned from sale in China to develop an upcoming AI model, according to a report by
More
Unconventional AI, the new venture launched by former Databricks head of AI Naveen Rao, has confirmed a massive $475 million seed round at a valuation of $4.5 billion — one of the
More
Scientists report they are nearing a turning point in drug development as AI-designed antibodies begin to show properties comparable to commercial medicines. The progress comes just one year after biologists first used
More